GlassScriptPhysician profile
Samita Shah
NPI 1326436395
$2,640.26
in general payments reported to CMS, 2019-2025
20 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $430 · 2022: $20.13 · 2023: $498 · 2024: $1,385 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,009.84 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.39 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $295.00 | 2023-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $238.24 | 2021-2025 | Winlevi, Ilumya |
| Janssen Biotech, INC. | $209.91 | 2021-2024 | Tremfya |
| Lilly USA, LLC | $204.25 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $194.80 | 2021-2024 | Otezla |
| Genzyme Corporation | $156.48 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $154.65 | 2021-2025 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $142.76 | 2021-2024 | Cabtreo |
| Novartis Pharmaceuticals Corporation | $138.65 | 2023-2025 | |
| Pfizer INC. | $104.13 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2025 | |
| Biofrontera INC. | $55.66 | 2023-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Galderma Laboratories, L.P. | $55.38 | 2024 | Aklief |
| Dermavant Sciences, INC. | $48.31 | 2023-2024 | Vtama |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $40.48 | 2024 | Bimzelx |
| Leo Pharma INC. | $36.61 | 2024 | Adbry |
| Organon LLC | $30.51 | 2025 | Vtama |
| Mission Pharmacal Company | $14.78 | 2021 | |
| Verrica Pharmaceuticals INC. | $13.28 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samita Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.